Zhiling Yan

3.4k total citations · 2 hit papers
104 papers, 1.2k citations indexed

About

Zhiling Yan is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Zhiling Yan has authored 104 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Hematology, 38 papers in Molecular Biology and 31 papers in Oncology. Recurrent topics in Zhiling Yan's work include CAR-T cell therapy research (16 papers), Hematopoietic Stem Cell Transplantation (15 papers) and MicroRNA in disease regulation (11 papers). Zhiling Yan is often cited by papers focused on CAR-T cell therapy research (16 papers), Hematopoietic Stem Cell Transplantation (15 papers) and MicroRNA in disease regulation (11 papers). Zhiling Yan collaborates with scholars based in China, United States and Singapore. Zhiling Yan's co-authors include Kailin Xu, Jiang Cao, Hai Cheng, Wei Sang, Lingyu Zeng, Yufeng Yao, Li Shi, Bin Pan, Lichao Sun and Chong Chen and has published in prestigious journals such as Blood, PLoS ONE and Scientific Reports.

In The Last Decade

Zhiling Yan

94 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MA-SAM: Modality-agnostic SAM adaptation for 3D medical image segmentation

2024 71 citations Zhiling Yan, Lichao Sun et al. profile →
Sora: A Review on Background, Technology, Limitations, and Opportunities of Large Vision Models

2024 53 citations Zhiling Yan, Lichao Sun et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhiling Yan China	19	435	281	245	208	197	104	1.2k
Rajan Dewar United States	13	510 1.2×	346 1.2×	180 0.7×	163 0.8×	192 1.0×	32	1.2k
Aibin Liang China	19	689 1.6×	498 1.8×	114 0.5×	202 1.0×	182 0.9×	117	1.5k
Jin Ding China	22	465 1.1×	439 1.6×	77 0.3×	489 2.4×	173 0.9×	83	1.6k
Georgios Georgakis United States	21	830 1.9×	511 1.8×	69 0.3×	368 1.8×	166 0.8×	55	1.6k
Marek Kamiński Poland	18	352 0.8×	211 0.8×	163 0.7×	248 1.2×	132 0.7×	139	1.3k
Asha Das United States	24	511 1.2×	395 1.4×	46 0.2×	324 1.6×	204 1.0×	54	1.6k
Shidong Jia United States	16	1.2k 2.8×	463 1.6×	117 0.5×	140 0.7×	512 2.6×	71	2.0k
Jae‐Beom Kim South Korea	21	795 1.8×	225 0.8×	176 0.7×	109 0.5×	98 0.5×	46	1.9k
Youngil Koh South Korea	21	675 1.6×	729 2.6×	353 1.4×	121 0.6×	211 1.1×	143	1.7k
Qingzhao Zhang China	19	354 0.8×	118 0.4×	219 0.9×	744 3.6×	67 0.3×	103	1.5k

Countries citing papers authored by Zhiling Yan

Since Specialization

Citations

This map shows the geographic impact of Zhiling Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhiling Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhiling Yan more than expected).

Fields of papers citing papers by Zhiling Yan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhiling Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhiling Yan. The network helps show where Zhiling Yan may publish in the future.

Co-authorship network of co-authors of Zhiling Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Zhiling Yan. A scholar is included among the top collaborators of Zhiling Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhiling Yan. Zhiling Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Tianyi, Zhiling Yan, Yuqing Lei, et al.. (2025). CellMix: A General Instance Relationship-Based Method for Data Augmentation Toward Pathology Image Classification. IEEE Transactions on Neural Networks and Learning Systems. 36(9). 16020–16034.

Yan, Zhiling, Tianhui Liu, Lijuan Qi, et al.. (2025). CAR T-Cell therapy in chronic myeloid leukemia patients with lymphoid blast crisis: A multicenter clinical analysis. Cancer Letters. 621. 217688–217688.

Xu, Yan, et al.. (2024). Free fatty acid receptor-4 regulates T-cell-mediated allogeneic reaction through activating an aryl hydrocarbon receptor pathway. Acta Pharmaceutica Sinica B. 15(1). 224–238.

Liu, Yixin, et al.. (2024). A Survey of AI-Generated Content (AIGC). ACM Computing Surveys. 57(5). 1–38. 45 indexed citations

Yan, Zhiling, Chuanyin Li, Shuyuan Liu, et al.. (2024). Association of HLA class I and II genes with cervical cancer susceptibility in a Han Chinese population. HLA. 103(1). e15340–e15340. 3 indexed citations

Liu, Yang, Nian Li, Ying Wang, et al.. (2023). A combination of pre-infusion serum ferritin, CRP and IL-6 predicts outcome in relapsed/refractory multiple myeloma patients treated with CAR-T cells. Frontiers in Immunology. 14. 1169071–1169071. 17 indexed citations

Yang, Jia, Yu Li, Chuanyin Li, et al.. (2022). The Association of TNF-&alpha; Promoter Polymorphisms with Genetic Susceptibility to Cervical Cancer in a Chinese Han Population. Dove Medical Press (Taylor and Francis Group). 6 indexed citations

Chen, Kerong, Zhiling Yan, Xudong Dong, et al.. (2022). Genetic Polymorphisms in microRNA Genes Targeting PI3K/Akt Signal Pathway Modulate Cervical Cancer Susceptibility in a Chinese Population. Frontiers in Genetics. 13. 5 indexed citations

Yang, Hongying, Lijuan Yang, Li Shi, et al.. (2019). Human papillomavirus type 16 E6 and E7 gene variations associated with cervical cancer in a Han Chinese population. Infection Genetics and Evolution. 73. 13–20. 20 indexed citations

10.

Wu, Qingyun, Mengmeng Ma, Sen Zhang, et al.. (2019). Disruption of R867 and Y613 interaction plays key roles in JAK2 R867Q mutation caused acute leukemia. International Journal of Biological Macromolecules. 136. 209–219. 6 indexed citations

11.

Yan, Zhiling, Chuanyin Li, Longyu Yang, et al.. (2019). Human Papillomavirus Type 16 E1 Mutations Associated with Cervical Cancer in a Han Chinese Population. International Journal of Medical Sciences. 16(7). 1042–1049. 8 indexed citations

12.

Yu, Di, Bin Zhang, Huan-Xin Zhang, et al.. (2018). [Risk Factors and Prognosis of Hepatic cGVHD after Allogeneic Hematopoietic Stem Cell Transplantation].. PubMed. 26(4). 1174–1179. 1 indexed citations

13.

Yan, Zhiling, Li Shi, Xiaona Wang, et al.. (2018). The association of human papillomavirus type 16 E2 variations with cervical cancer in a Han Chinese population. Infection Genetics and Evolution. 64. 241–248. 9 indexed citations

14.

Wu, Qingyun, Mengmeng Ma, Sen Zhang, et al.. (2018). Loss of K607 and E877 interaction is a key reason for JAK2 K607N mutation caused acute myeloid leukemia. International Journal of Biological Macromolecules. 124. 1123–1131. 7 indexed citations

15.

Yang, Chen, Tingting Shao, Huihui Zhang, et al.. (2018). MiR-425 expression profiling in acute myeloid leukemia might guide the treatment choice between allogeneic transplantation and chemotherapy. Journal of Translational Medicine. 16(1). 267–267. 16 indexed citations

16.

Yan, Zhiling, Zhenyu Li, Huanxin Zhang, et al.. (2015). [Efficacy of high-dose dexamethasone plus low-dose rituximab as a second-line treatment in 65 patients with primary immune thrombocytopenia].. PubMed Central. 36(3). 206–9. 2 indexed citations

17.

Zhu, Feng, Xiaomin Zhong, Jianlin Qiao, et al.. (2015). Cytotoxic T Lymphocyte Antigen-4 Down-Regulates T Helper 1 Cells by Increasing Expression of Signal Transducer and Activator of Transcription 3 in Acute Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 22(2). 212–219. 7 indexed citations

18.

Li, Yanjie, Depeng Li, Zhiling Yan, et al.. (2014). Potential relationship and clinical significance of miRNAs and Th17 cytokines in patients with multiple myeloma. Leukemia Research. 38(9). 1130–1135. 12 indexed citations

19.

Chen, Wei, Zhenyu Li, Zhiling Yan, et al.. (2012). CXCR4-transduced mesenchymal stem cells protect mice against graft-versus-host disease. Immunology Letters. 143(2). 161–169. 19 indexed citations

20.

Zeng, Lingyu, Shuang Ding, Zhiling Yan, et al.. (2012). Irradiation induces homing of donor endothelial progenitor cells in allogeneic hematopoietic stem cell transplantation. International Journal of Hematology. 95(2). 189–197. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact